ATTR- CMにおけるタファミディスの使用: THAOS レジストリの洞察 投与量独立の含有基準と患者ベースラインの変動
Tayyaba Abdullah1, Syeda Ayesha Bukhari2, Tayyaba Imran2
1Nishtar Medical University, Multan, Pakistan. tayyabaabdullah16@gmail.com.
Cardiovascular drugs and therapy
|August 30, 2025
まとめ
No abstract available in PubMed .
関連する概念動画
01:20Desensitization and Tachyphylaxis
2.2K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.2K
01:12Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382